BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Golay J, Andrea AE. Combined Anti-Cancer Strategies Based on Anti-Checkpoint Inhibitor Antibodies. Antibodies (Basel) 2020;9:E17. [PMID: 32443877 DOI: 10.3390/antib9020017] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Messeha SS, Zarmouh NO, Soliman KFA. Polyphenols Modulating Effects of PD-L1/PD-1 Checkpoint and EMT-Mediated PD-L1 Overexpression in Breast Cancer. Nutrients 2021;13:1718. [PMID: 34069461 DOI: 10.3390/nu13051718] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
2 Tsikala-Vafea M, Belani N, Vieira K, Khan H, Farmakiotis D. Use of antibiotics is associated with worse clinical outcomes in patients with cancer treated with immune checkpoint inhibitors: A systematic review and meta-analysis. Int J Infect Dis 2021;106:142-54. [PMID: 33771672 DOI: 10.1016/j.ijid.2021.03.063] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
3 Andrea AE, Chiron A, Mallah S, Bessoles S, Sarrabayrouse G, Hacein-Bey-Abina S. Advances in CAR-T Cell Genetic Engineering Strategies to Overcome Hurdles in Solid Tumors Treatment. Front Immunol 2022;13:830292. [PMID: 35211124 DOI: 10.3389/fimmu.2022.830292] [Reference Citation Analysis]
4 Wojas-Krawczyk K, Krawczyk P, Gil M, Strzemski M. Two Complementarity Immunotherapeutics in Non-Small-Cell Lung Cancer Patients-Mechanism of Action and Future Concepts. Cancers (Basel) 2021;13:2836. [PMID: 34200219 DOI: 10.3390/cancers13112836] [Reference Citation Analysis]
5 Andrea AE, Chiron A, Bessoles S, Hacein-Bey-Abina S. Engineering Next-Generation CAR-T Cells for Better Toxicity Management. Int J Mol Sci 2020;21:E8620. [PMID: 33207607 DOI: 10.3390/ijms21228620] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 3.5] [Reference Citation Analysis]
6 Bippes CC, Kohler C, Garcia-Tirado E, Burri R, Frauenknecht T, Gerard MA, Salat M, Allenspach R, Agca C, Wu Z, Trost A, Bogner B, Meyer P, Scholl HPN, Reitsamer H, Flammer J, Neutzner A. Endosomal disentanglement of a transducible artificial transcription factor targeting endothelin receptor A. Mol Ther 2021:S1525-0016(21)00473-1. [PMID: 34547467 DOI: 10.1016/j.ymthe.2021.09.018] [Reference Citation Analysis]
7 Wang J, Mamuti M, Wang H. Therapeutic Vaccines for Cancer Immunotherapy. ACS Biomater Sci Eng 2020;6:6036-52. [PMID: 33449675 DOI: 10.1021/acsbiomaterials.0c01201] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]